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Background: Extracorporeal membrane oxygenation (ECMO) is a lifesaving therapy used in critically ill patients with 
severe cardiopulmonary dysfunction. Continuous renal replacement therapy (CRRT) is supplemented to treat fluid 
overload, acute kidney injury, and electrolyte disturbances during ECMO. However, the best time to initiate CRRT is 
not well-defined. We performed this study to identify the optimal timing of CRRT for ECMO. 
Methods: We conducted a multicenter retrospective cohort study of 296 patients over 12 years. Patients received 
CRRT during ECMO at Seoul National University Hospital, Seoul National University Bundang Hospital, or Yonsei 
University Hospital. We assigned patients to an early or late CRRT group depending on the CRRT initiation time. We 
considered early CRRT to be CRRT instituted within 72 hours of ECMO initiation.
Results: Among 296 patients, 212 patients (71.6%) received early CRRT. After using a propensity score matching 
method, 47 patients were included in each group. The time from ECMO initiation to CRRT initiation was 1.1 ± 0.9 
days in the early CRRT group and 14.6 ± 18.6 days in the late CRRT group. No difference in patients’ mortality (P = 
0.834) or hospital stay (P = 0.627) between the early and late CRRT groups was found. After adjusting all covariables, 
there was no significant difference in mortality between the early and late CRRT groups (hazard ratio, 0.697; 95% 
confidence interval, 0.410-1.184; P = 0.182).
Conclusion: This study showed that early CRRT may not be superior to late CRRT in ECMO patients. Further clinical 
trials are warranted.
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Introduction
Extracorporeal membrane oxygenation (ECMO) is a 
lifesaving therapy used in critically ill patients with se-
vere cardiopulmonary dysfunction. This technique was 
first successfully used in 1972 in patients with acute post-
traumatic respiratory failure [1]. At first, ECMO was pri-
marily used for respiratory failure of newborns. But after 
the H1N1 influenza pandemic, several studies were con-
ducted on ECMO for adults, and ECMO techniques have 
since improved [2-5].
Continuous renal replacement therapy (CRRT) is of-
ten applied to treat uremia, fluid overload, electrolyte 
disturbances, and acid-base abnormalities in critically 
ill patients. Positive volume balance and acute kidney 
injury (AKI) are well-recognized risk factors for mortal-
ity in patients receiving ECMO [6-9]. The most common 
causes for initiating renal replacement therapy in ECMO 
patients are fluid overload (43%), prevention of fluid 
overload (16%), AKI (35%), and electrolyte disturbances 
(4%) [10]. CRRT is supplemented to 40-60% of ECMO 
patients [7,11-13]. However, the best time to initiate 
CRRT is not well-defined. Early initiation of CRRT may be 
effective in managing fluid overload, AKI, and acid-base 
disturbances. On the other hand, late initiation of CRRT 
has the advantage of allowing time for spontaneous renal 
recovery. Although there are many studies comparing the 
early initiation of CRRT with the late initiation of CRRT in 
critically ill patients, there are few studies on the timing 
of CRRT in ECMO patients [12,13].
Thus, we conducted a multicenter retrospective cohort 
study to evaluate the risk of mortality associated with the 
timing of CRRT in ECMO patients. We hypothesized that 
early initiation of CRRT is associated with reduced mor-
tality compared with late initiation of CRRT. To minimize 
confounding biases, we used a propensity score analysis.
Methods
Study design and patients
This retrospective study included adult patients 15 
years or older. All patients underwent ECMO treatment at 
Seoul National University Bundang Hospital, Seoul Na-
tional University Hospital, or Yonsei University Severance 
Hospital, all of which are tertiary referral hospitals. From 
January 2005 to May 2016, 838 patients received ECMO 
treatment. Patients were excluded if they did not receive 
CRRT (n = 383), if they had been receiving CRRT before 
initiating ECMO (n = 148), or if they received ECMO and 
CRRT at the same time (n = 11). Finally, 296 patients were 
enrolled in this study (Fig. 1).
This study was approved by the Institutional Review 
Board of Seoul National University Hospital (H1607-072-
776), Seoul National University Bundang Hospital (B-
1607/354-101), and Yonsei University Severance Hospital 
(4-2016-0867).
Measurements and definitions
We collected the following patient data from medical 
records: age, sex, body mass index (BMI), ECMO settings, 
intensive care unit days prior to ECMO, CRRT settings, 
CRRT duration, fluid balance, white blood cells, hemo-
globin, platelet, C-reactive protein (CRP), albumin, total 
cholesterol, total bilirubin, blood urea nitrogen (BUN), 
838 patients who received ECMO were enrolled
296 patients were analyzed
Propensity score matching
542 patients were excluded (n)
- Did not receive CRRT (383)
- Already received CRRT before ECMO (148)
- Received ECMO and CRRT at the same time (11)
212 in early CRRT group
47 in early CRRT group
84 in late CRRT group
47 in late CRRT group
Figure 1. Flow chart of the study popu-
lation. 
CRRT, continuous renal replacement ther-
apy; ECMO, extracorporeal membrane oxy-
genation.
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creatinine (Cr), estimated glomerular filtration rate 
(eGFR), sodium, potassium, chloride, total CO2 (TCO2), 
and pH. Clinical and laboratory data were obtained 
within the 24-hour period prior to ECMO initiation. We 
assessed each patient’s history of comorbidities based 
on the International Classification of Disease, 10th revi-
sion (ICD 10), as follows; hypertension (I10-I15), diabe-
tes mellitus (E10-E14), heart failure (I50), and chronic 
obstructive pulmonary disease (J40-J46). BMI was cal-
culated using the following formula: BMI = body weight 
(kg) / height (m)2 [14]. Fluid balance was calculated as the 
difference between fluid in and out within 72 hours after 
ECMO initiation: fluid balance = (total fluid intake [mL] - 
total fluid output [mL]) / body weight (kg) [7]. We used the 
modification of diet in renal disease formula with serum 
Cr, age, and sex: eGFR (mL/min/1.73 m2) = 186 × serum 
creatinine (mg/dL)-1.154 × age (years)-0.203 × 0.742 (if female) 
[15]. 
We assigned patients to either the early or late CRRT 
group depending on the CRRT initiation time. We con-
sidered early CRRT to be CRRT added within 72 hours 
of ECMO initiation based on fluid balance [7,16]. The 
primary outcome was overall mortality within 30 days 
after ECMO initiation. Data from patients who survived 
30 days after ECMO initiation were censored, and patient 
data lost to follow-up before 30 days after ECMO initia-
tion were censored at the last follow-up date.
Statistical analysis
To reduce potential confounding biases in the study co-
hort, propensity score matching was applied. Propensity 
scores for each patient were calculated using a multivari-
ate logistic regression analysis with the following covari-
ates: age, sex, white blood cells, hemoglobin, platelets, 
albumin, sodium, potassium, BUN, Cr, eGFR, fluid bal-
ance, CRP, TCO2, and pH. We used a greedy 8-1-digit 
matching algorithm to match patients in a 1:1 ratio. Pro-
pensity score matching was conducted with SAS ver. 9.1.3 
(SAS Institute, Cary, NC, USA).
Continuous variables were presented as the mean ± 
standard deviation, and categorical variables were pre-
sented as frequencies and percentages. The intergroup 
comparison of continuous variables was analyzed by 
Student’s t test. A chi-square test was used for intergroup 
comparisons of categorical variables. The survival curve 
was estimated using the Kaplan-Meier method, and the 
statistical significance was calculated using the log-rank 
test. The Cox proportional hazard regression model was 
used to evaluate the crude hazard ratio (HR) and propen-
sity score-adjusted HR between mortality and the timing 
of CRRT in ECMO patients. A value of P < 0.05 was used 
to determine statistical significance. IBM SPSS Statistics 
version 20 (IBM Co., Armonk, NY, USA) was used for 
all data analyses except the propensity score matching 
method. 
Results
A total of 296 patients were enrolled in the study, of 
which 212 were in the early CRRT group and 84 were in 
the late CRRT group. The mean age of the patients was 
58.8 ± 16.6 years, and 194 (65.5%) were male. The mean 
time from ECMO initiation to receive CRRT was 0.8 ± 0.8 
days in the early CRRT group and 17.4 ± 30.4 days in the 
late CRRT group. Among the participants, 210 (70.9%) 
and 86 (29.1%) received venoarterial (VA) and venove-
nous (VV) ECMO support, respectively. The reasons for 
ECMO support were non-operative cardiovascular causes 
(56.1%), non-adult respiratory distress syndrome (ARDS) 
lung causes (15.5%), ARDS (14.5%), post-cardiotomy 
(8.1%), and other causes (5.7%). The data showed that 
118 (39.9%) patients underwent cardiopulmonary resus-
citation (CPR) within the 24-hour period prior to ECMO 
initiation. Last, 188 (89.5%) patients with cardiogenic 
shock received VA ECMO, and 81 (94.2%) patients with 
respiratory failure received VV ECMO.
Clinical characteristics of the patients in this study are 
shown in Table 1. The late CRRT group received more VV 
ECMO support than the early CRRT group. Reasons for 
ECMO support were associated with the timing of CRRT 
initiation. CPR within the 24-hour period prior to ECMO 
initiation was higher in the early CRRT group than in 
the late CRRT group. Mortality was significantly lower in 
the late CRRT group than in the early CRRT group, and 
hospital stay was significantly shorter in the early CRRT 
group than in the late CRRT group. The late CRRT group 
had a higher CRP level than the early CRRT group. Serum 
Cr was significantly lower in the late CRRT group than in 
the early CRRT group, and eGFR was significantly higher 
in the late CRRT group than in the early CRRT group. The 
early CRRT group had significantly lower TCO2 and pH 
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levels compared with the late CRRT group. After using 
a propensity score matching method, 47 patients were 
included in each cohort. The mean age was 60.5 ± 15.9 
years, and 59 (62.8%) patients were male. The mean time 
from ECMO initiation to CRRT initiation was 1.1 ± 0.9 
days in the early CRRT group and 14.6 ± 18.6 days in the 
Table 1. Baseline characteristics of matched patients
Parameter
Entire cohort Propensity-matched cohort
Early CRRT
(n = 212)
Late CRRT
(n = 84)
P value
Early CRRT
(n = 47)
Late CRRT
(n = 47)
P value
Age (yr) 58.4 ± 17.1 59.7 ± 15.4 0.533 59.4 ± 16.9 61.7 ± 15.0 0.502
Sex, male 139 (65.6) 55 (65.5) 0.988 26 (55.3) 33 (70.2) 0.135
Body mass index (kg/m2) 24.3 ± 4.4 25.3 ± 16.8 0.579 24.3 ± 3.8 24.8 ± 13.4 0.823
Hypertension 60 (28.3) 31 (36.9) 0.163 15 (31.9) 20 (42.6) 0.286
Diabetes mellitus 53 (25.0) 20 (23.8) 0.830 11 (23.4) 13 (27.7) 0.636
Heart failure 57 (26.9) 19 (22.6) 0.449 10 (21.3) 13 (27.7) 0.472
COPD 21 (9.9) 11 (13.1) 0.426 6 (12.8) 5 (10.6) 0.748
Mode of ECMO, VV 46 (21.7) 40 (47.6) < 0.001 14 (29.8) 17 (36.2) 0.510
Reasons for ECMO < 0.001 0.859
   Post-cardiotomy 20 (9.4) 4 (4.8) 0.184 3 (6.4) 3 (6.4) 1.000
   Non-operative CV causes 132 (62.3) 34 (40.5) 0.001 29 (61.7) 24 (51.1) 0.298
   ARDS 25 (11.8) 18 (21.4) 0.034 5 (10.6) 7 (14.9) 0.536
   Non-ARDS lung causes 23 (10.8) 23 (27.4) < 0.001 7 (14.9) 10 (21.3) 0.421
   Others 12 (5.7) 5 (6.0) 1.000 3 (6.4) 3 (6.4) 1.000
CPR within 24 hr 94 (44.3) 24 (28.6) 0.012 19 (40.4) 17 (36.2) 0.671
ICU days prior to ECMO 3.2 ± 11.2 2.8 ± 4.8 0.752 5.5 ± 17.3 2.1 ± 4.0 0.202
CRRT settings
   Blood flow rate (mL/min) 107.9 ± 22.0 109.1 ± 19.4 0.666 106.1 ± 22.9 110.7 ± 20.5 0.335
   Replacement volume (L/hr) 1.2 ± 0.3 1.1 ± 0.3 0.444 1.2 ± 0.4 1.1 ± 0.4 0.663
   Dialysate volume (L/hr) 1.2 ± 0.3 1.2 ± 0.3 0.667 1.2 ± 0.3 1.2 ± 0.3 0.701
CRRT duration (d) 6.0 ± 6.9 9.3 ± 12.9 0.194 8.9 ± 10.3 10.8 ± 15.3 0.689
Fluid balance (mL/kg) 108.7 ± 96.8 101.2 ± 107.8 0.496 108.3 ± 94.6 104.8 ± 110.0 0.868
Hospital stay (d) 31.1 ± 45.7 50.2 ± 46.4 0.001 49.6 ± 70.5 43.8 ± 38.2 0.627
Mortality 152 (71.7) 43 (51.2) 0.001 28 (59.6) 27 (57.4) 0.834
White blood cells (×103/μL) 13.9 ± 17.8 12.8 ± 5.9 0.599 12.4 ± 6.5 12.8 ± 6.3 0.751
Hemoglobin (g/dL) 10.4 ± 2.6 10.9 ± 2.1 0.113 11.3 ± 2.9 10.7 ± 2.2 0.309
Platelet (×103/μL) 133.9 ± 90.5 143.9 ± 80.4 0.379 137.9 ± 104.9 143.7 ± 81.3 0.767
C-reactive protein (mg/dL) 62.4 ± 83.5 100.5 ± 105.0 0.005 79.7 ± 99.1 80.3 ± 95.2 0.975
Albumin (g/dL) 2.6 ± 0.7 2.7 ± 0.6 0.443 2.7 ± 0.6 2.7 ± 0.6 0.643
Total cholesterol (mg/dL) 105.9 ± 51.9 106.6 ± 53.3 0.914 97.8 ± 40.2 102.0 ± 43.2 0.631
Blood urea nitrogen (mg/dL) 30.2 ± 17.0 28.9 ± 19.5 0.592 29.4 ± 14.8 30.6 ± 19.2 0.731
Creatinine (mg/dL) 1.2 ± 0.9 1.2 ± 0.9 < 0.001 1.5 ± 0.9 1.5 ± 1.0 0.928
eGFR (mL/min/1.73 m2) 82.3 ± 54.8 82.3 ± 54.8 < 0.001 61.4 ± 33.2 61.4 ± 35.2 1.000
Sodium (mmol/L) 140.9 ± 7.1 140.9 ± 7.1 0.231 140.7 ± 6.9 141.8 ± 6.4 0.438
Potassium (mmol/L) 4.1 ± 0.7 4.1 ± 0.7 0.939 4.1 ± 0.8 4.1 ± 0.8 0.976
Chloride (mmol/L) 104.4 ± 7.1 104.4 ± 7.1 0.413 104.1 ± 7.2 106.5 ± 6.4 0.099
Total CO2 (mmol/L) 22.9 ± 6.1 22.9 ± 6.1 < 0.001 20.3 ± 5.5 20.8 ± 5.5 0.639
pH 7.3 ± 0.2 7.3 ± 0.2 0.004 7.3 ± 0.2 7.3 ± 0.2 0.552
Data are presented as the mean ± standard deviation or number (%).
ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; CRRT, continuous renal replacement 
therapy; CV, cardiovascular; ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration rate; ICU, intensive care unit; VV, venovenous. 
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late CRRT group. There were no statistical differences be-
tween the early and late CRRT groups in terms of ECMO 
mode, reasons for ECMO support, CPR within the 24-
hour period prior to ECMO initiation, patient mortality, 
hospital stay, CRP, serum Cr, eGFR, TCO2, or pH.
Table 2 shows the results of the Cox proportional haz-
ards analyses used to identify an association between 
the timing of CRRT and the overall mortality in ECMO 
patients. The early CRRT group had poorer survival than 
the late CRRT group, based on a univariate analysis (HR, 
0.427; 95% confidence interval [CI], 0.304-0.601; P < 
0.001) and a multivariate analysis (HR, 0.432; 95% CI, 
0.295-0.632; P < 0.001) of the entire cohort. In the pro-
pensity-matched patients, however, the late CRRT group 
had no significant survival benefit compared to the early 
CRRT group, as assessed by crude analysis (HR, 0.708; 
95% CI, 0.417-1.202; P = 0.201). After adjusting for all 
covariables, there was no significant association between 
the timing of CRRT and mortality (HR, 0.697; 95% CI, 
0.410-1.184; P = 0.182).
The Kaplan-Meier survival analyses are shown in Fig. 2. 
For the entire cohort, the cumulative incidence of overall 
mortality was higher in the early CRRT group than in the 
late CRRT group (P < 0.001). However, there was no sig-
nificant difference in overall mortality between the early 
CRRT group and the late CRRT group for the propensity-
matched cohort (P = 0.199).
Fig. 3 shows the subgroup analyses of the estimated 
HR for the timing of CRRT and overall mortality in the 
propensity-matched patients. A higher mortality risk was 
observed in early-CRRT-group patients with Cr levels ≥ 1.3 
mg/dL (HR, 1.046; 95% CI, 0.507-2.160; P = 0.903) than in 
late-CRRT-group patients with Cr levels < 1.3 mg/dL. Late-
CRRT-group patients with Cr levels < 1.3 mg/dL showed 
better survival than early-CRRT-group patients with Cr 
levels < 1.3 mg/dL (HR, 0.438; 95% CI, 0.196-0.982; P = 
0.045). However, when we conducted a comparison (using 
two HRs) between patients with Cr levels < 1.3 mg/dL and 
those with Cr levels ≥ 1.3 mg/dL, there was no significant 
difference between these two groups (P = 0.059).
Discussion
We performed a multicenter retrospective cohort study 
of 296 critically ill patients who received ECMO to inves-
Table 2. Cox proportional hazards analyses of CRRT initiation 
and mortality
Model HR (95% CI) P value
Entire cohort
   Unadjusted 0.427 (0.304-0.601) < 0.001
   Multivariable adjusted* 0.432 (0.295-0.632) < 0.001
Matched cohort
   Unadjusted 0.708 (0.417-1.202) 0.201
   Adjusted for propensity score 0.697 (0.410-1.184) 0.182
CI, confidence interval; CRRT, continuous renal replacement therapy; HR, hazard 
ratio. 
*Adjusted for age, sex, white blood cells, hemoglobin, platelets, albumin, 
sodium, potassium, blood urea nitrogen, creatinine, estimated glomerular 
filtration rate, fluid balance, C-reactive protein, total CO2, and pH.
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Figure 2. Kaplan-Meier survival according to continuous renal replacement therapy (CRRT) initiation among (A) all patients and (B) 
propensity-matched patients.
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tigate the risk of mortality associated with the timing of 
CRRT in ECMO patients. We found that the early CRRT 
group may not be superior to the late CRRT group in 
ECMO patients, and there was no significant difference in 
hospital stay between the early CRRT group and the late 
CRRT group. 
The question of when to initiate CRRT in critically ill 
patients with AKI has long been a controversial concern 
for clinicians [17]. There is a consensus that CRRT should 
be initiated urgently following life-threatening com-
plications of AKI, such as refractory volume overload, 
hyperkalemia, or metabolic acidosis. But there remains 
controversy over when to start CRRT in critically ill pa-
tients without such complications [18]. Recent data have 
shown that the traditional indications for initiating CRRT 
are less commonly encountered in critically ill patients 
(nor are they the most common triggers for the initia-
tion of CRRT) [19,20]. In clinical practice, the decision to 
initiate CRRT varies. It is determined by physician beliefs 
and patient and organizational characteristics [21,22]. In 
addition, the definitions of “early” and “late” are relative. 
Previous studies have used serum urea nitrogen, serum 
creatinine, urine output, timing relative to intensive care 
unit admission, and timing relative to the development of 
traditional indications for initiating CRRT (such as fluid 
overload, hyperkalemia, and metabolic acidosis) as cri-
teria to distinguish early CRRT from late CRRT [19,20,23]. 
This heterogeneity across studies in defining early and 
late CRRT has been a fundamental barrier to establishing 
definitive guidelines for the timing of CRRT initiation in 
critically ill patients. In the current study, we considered 
early CRRT to be CRRT added within 72 hours of ECMO 
initiation. We used propensity score matching to adjust 
prognostically important baseline characteristics. Several 
studies have revealed that fluid overload is the most com-
mon reason for initiating CRRT in ECMO patients, and 
fluid overload is significantly associated with mortality, 
impaired oxygenation, and longer length of hospital stay 
[7,10,24,25]. Fluid balance at day three is a particularly 
robust independent predictor for mortality in ECMO 
patients [7]. A recent randomized controlled trial (RCT) 
used volume status at 72 hours as the criterion for divid-
ing the early and late CRRT groups in critically ill patients 
[16]. Thus, we chose 72 hours to distinguish between the 
early and late CRRT groups in ECMO patients.
In theory, the early initiation of CRRT has advantages 
for managing volume accumulation, acid-base disorders, 
electrolyte imbalances, and complications of uremia 
[26,27]. Despite the controversy, the early initiation of 
CRRT may confer benefits through modulating immune 
function and removing inflammatory mediators [28]. On 
the other hand, the late initiation of CRRT could allow 
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Figure 3. Cox proportional hazards analyses of CRRT initiation and mortality in the subgroups of propensity-matched patients. 
CI, confidence interval; CRRT, continuous renal replacement therapy; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HR, 
hazard ratio; HTN, hypertension.
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time for spontaneous renal recovery, helping patients 
to avoid unnecessary CRRT [16,29]. Such patients may 
be at risk for complications of vascular access (such as 
bleeding or bacteremia) or complications of CRRT (in-
cluding intradialytic hypotension, subtherapeutic levels 
of essential medications, and hypersensitivity to the 
extracorporeal circuit). Many observational studies and 
meta-analyses have demonstrated that the early initia-
tion of CRRT in critically ill patients shows better patient 
survival than the late initiation of CRRT [27,30,31]. How-
ever, a meta-analysis of RCTs revealed that there was 
no significant difference in mortality between early and 
late CRRT groups [32]. Specifically, three RCTs showed 
that early initiation of CRRT had a beneficial effect on 
patient survival, but six RCTs showed that early initia-
tion of CRRT did not improve patient survival (compared 
to late initiation of CRRT). The same analysis revealed 
there was no significant difference between early and late 
CRRT groups regarding intensive care unit length of stay, 
hospital stay, renal function recovery, CRRT dependence, 
duration of CRRT, renal recovery time, or mechanical 
ventilation time. More recently, two well-designed RCTs 
(Effect of Early vs. Delayed Initiation of Renal Replace-
ment Therapy on Mortality in Critically Ill Patients with 
Acute Kidney Injury [ELAIN] and Artificial Kidney Initia-
tion in Kidney Injury [AKIKI] trials) yielded conflicting 
results. The ELAIN trial was a single-center RCT of 231 
critically ill patients in Germany [26]. Patients with stage 
2 AKI (by Kidney Disease: Improving Global Outcomes 
[KDIGO] standards) or with plasma neutrophil gelatin-
ase-associated lipocalin > 150 ng/mL were enrolled. Ear-
ly CRRT was defined as initiating CRRT within 8 hours of 
a diagnosis of KDIGO stage 2 AKI, and delayed CRRT was 
defined as initiating CRRT within 12 hours of any of the 
following: KDIGO stage 3 AKI, BUN > 100 mg/dL, serum 
potassium > 6 mmol/L (and/or electrocardiography ab-
normalities), serum magnesium > 4 mmol/L, anuria, or 
organ edema resistant to diuretic treatment. The ELAIN 
trial revealed that early initiation of CRRT significantly 
reduced 90-day mortality. The AKIKI trial, a multicenter 
RCT of 620 patients in intensive care units in France, 
yielded different results [16]. The AKIKI trial enrolled pa-
tients with KDIGO stage 3 AKI who required mechanical 
ventilation, catecholamine infusion, or both, and did not 
have a potentially life-threatening complication directly 
related to renal failure. Early CRRT was defined as initiat-
ing CRRT immediately after randomization, and delayed 
CRRT was defined as initiating CRRT with at least one of 
the following criteria: BUN > 112 mg/dL, serum potas-
sium > 6 mmol/L, pH < 7.15, acute pulmonary edema, or 
oliguria for more than 72 hours after randomization. This 
study demonstrated that mortality at day 60 did not differ 
significantly between the early and delayed groups.
In patients with ECMO, AKI and receiving CRRT are 
independent risk factors for mortality [8,33,34]. Thus, 
prevention of AKI and optimization of CRRT can improve 
patient survival. However, there have been very few stud-
ies on the timing of CRRT in ECMO patients [12,13]. In 
a single-center study of 153 pediatric cardiac patients 
receiving ECMO, the early CRRT group showed increased 
mortality [13]. Early CRRT was defined as initiating CRRT 
within 48 hours of ECMO initiation. The study compared 
the early CRRT group with an ECMO-only group. A total 
of 59 patients were included in the early CRRT group, and 
94 patients belonged to the ECMO-only group. Patients 
in the early CRRT group had a higher mortality (P < 0.001). 
In a multivariate logistic regression analysis, patients 
with early CRRT initiation had a tripled risk of mortal-
ity. However, the study did not compare the early CRRT 
group with a late CRRT group. Furthermore, a single-cen-
ter study of 200 adult patients undergoing ECMO showed 
opposite results [12]. Although that study was not aimed 
at the timing of CRRT in ECMO patients, it revealed 
that patients requiring late CRRT (relative to the time of 
ECMO insertion) had a higher risk of death. Both stud-
ies failed to consider fluid balance as a confounder. Our 
study included fluid balance as a confounder, and is the 
first to investigate the onset of CRRT by dividing patients 
into early and late CRRT groups.
To the best of our knowledge, this is the largest study to 
date to evaluate the risk of mortality associated with the 
timing of CRRT in ECMO patients. It is also the first study 
of CRRT and ECMO conducted using an Asian popula-
tion. In our study of the entire cohort, the late CRRT 
group had better survival than the early CRRT group. Se-
rum Cr was significantly higher in the early CRRT group 
than in the late CRRT group, and eGFR, TCO2, and pH 
were significantly lower in the early CRRT group than the 
late CRRT group. This finding implies that the early CRRT 
group had more severe illness, and these differences are 
related to an increased risk of mortality. Thus, we used 
propensity score matching to minimize confounding bi-
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ases. After using the propensity score matching method, 
there was no significant difference in mortality or hospi-
tal stay between the groups. These results are consistent 
with the results of a recent RCT and a meta-analysis of 
RCTs [16,32]. 
Our study had some limitations. First, CRRT was not 
randomly administered to patients. Although propensity 
score matching was performed, this was a retrospective 
study. Several factors influencing outcomes were not 
fully collected, and the results could be subject to un-
measured confounders. Second, the definitions of early 
and late are arbitrary. We chose 72 hours to distinguish 
early CRRT from late CRRT, based on fluid balance. How-
ever, an earlier study selected 48 hours [13]. Furthermore, 
the time from ECMO support to initiation of CRRT varies 
widely. Third, there was a relatively small sample size in 
each group after propensity score matching. We included 
as many covariates as possible in relation to the initia-
tion of CRRT for calculating the propensity score. This 
reduced each sample size after propensity score match-
ing. Nevertheless, this is the largest study (and first mul-
ticenter analysis) to explore the timing of CRRT initiation 
in ECMO patients. Fourth, we did not have follow-up 
data, and therefore could not evaluate renal recovery and 
the effects of CRRT (such as correction of uremia, elec-
trolyte disturbance, and metabolic acidosis). 
In conclusion, our study demonstrated that early CRRT 
may not be superior to late CRRT in ECMO patients. 
CRRT may be delayed until more classic indications for 
CRRT are present. Further RCTs are needed to evaluate 
the effects of timing strategies on outcomes in ECMO pa-
tients. 
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